Brokerages Expect Alcentra Capital (ABDC) to Announce $0.30 Earnings Per Share

Equities analysts predict that Alcentra Capital (NASDAQ:ABDC) will post earnings of $0.30 per share for the current quarter, Zacks reports. Three analysts have issued estimates for Alcentra Capital’s earnings, with the lowest EPS estimate coming in at $0.24 and the highest estimate coming in at $0.33. Alcentra Capital reported earnings of $0.34 per share during the same quarter last year, which indicates a negative year over year growth rate of 11.8%. The firm is scheduled to issue its next earnings report on Thursday, May 3rd.

According to Zacks, analysts expect that Alcentra Capital will report full year earnings of $0.94 per share for the current year, with EPS estimates ranging from $0.82 to $1.10. For the next year, analysts anticipate that the company will post earnings of $0.89 per share, with EPS estimates ranging from $0.72 to $1.15. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that that provide coverage for Alcentra Capital.

How to Become a New Pot Stock Millionaire

Alcentra Capital (NASDAQ:ABDC) last issued its quarterly earnings results on Wednesday, March 14th. The asset manager reported $0.28 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.27 by $0.01. The company had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.77 million. Alcentra Capital had a positive return on equity of 10.56% and a negative net margin of 57.28%.

Several brokerages have commented on ABDC. ValuEngine downgraded Alcentra Capital from a “buy” rating to a “hold” rating in a research report on Friday. Keefe, Bruyette & Woods set a $7.00 price target on Alcentra Capital and gave the stock a “hold” rating in a research report on Thursday, March 15th. Raymond James Financial raised Alcentra Capital from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 11th. Finally, UBS raised Alcentra Capital from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 11th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $12.00.

NASDAQ ABDC traded up $0.14 during trading on Tuesday, hitting $6.84. The company’s stock had a trading volume of 14,057 shares, compared to its average volume of 89,324. The company has a market cap of $95.61, a P/E ratio of 5.18 and a beta of 0.57. Alcentra Capital has a 52 week low of $5.93 and a 52 week high of $14.61.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 4th. Stockholders of record on Friday, March 30th were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 10.53%. The ex-dividend date was Wednesday, March 28th. Alcentra Capital’s dividend payout ratio is presently 54.55%.

In other news, insider Branko Krmpotic acquired 10,000 shares of the stock in a transaction dated Tuesday, March 20th. The shares were acquired at an average cost of $6.15 per share, for a total transaction of $61,500.00. Following the completion of the transaction, the insider now owns 14,000 shares in the company, valued at approximately $86,100. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last 90 days, insiders have bought 14,750 shares of company stock worth $91,788. 4.96% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Bramshill Investments LLC bought a new stake in shares of Alcentra Capital during the fourth quarter valued at approximately $512,000. Caxton Corp acquired a new stake in Alcentra Capital in the 4th quarter valued at $500,000. Portland Investment Counsel Inc. acquired a new stake in Alcentra Capital in the 4th quarter valued at $168,000. Pacific Ridge Capital Partners LLC acquired a new stake in Alcentra Capital in the 4th quarter valued at $1,171,000. Finally, BlackRock Inc. boosted its stake in Alcentra Capital by 18.0% in the 4th quarter. BlackRock Inc. now owns 89,703 shares of the asset manager’s stock valued at $753,000 after buying an additional 13,669 shares in the last quarter. Institutional investors and hedge funds own 34.87% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at

Alcentra Capital Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital (ABDC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with's FREE daily email newsletter.

Leave a Reply